Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
mRNA | ZNF836 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |
mRNA | MED25 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-10 |
mRNA | RNF44 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | GRK3 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-10 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-10 |
mRNA | FKBP6 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-10 |